BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06698822-completion@plaintrial.com
DTSTAMP:20261027T191154Z
DTSTART;VALUE=DATE:20261019
SUMMARY:A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cre
 am in the Treatment of Cutaneous T-cell Lymphoma (CTCL)\, Stages IA\, IB\,
  and IIA — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06698822
URL:https://plaintrial.com/trial/NCT06698822
END:VEVENT
END:VCALENDAR